Short fiber microsphere scaffold matched with sequential bone regeneration as well as preparation method and application of short fiber microsphere scaffold
By using cerium and zinc-doped hydroxyapatite nanoparticles in bone repair materials, combined with hydrogel and electrospinning technology, the problem that bone repair materials cannot match bone regeneration rates is solved, and the bone repair materials are realized Controllable release of elements and regulation of mitochondrial function promote the bone healing process.
Patent Information
- Application Number
- CN202411218612.8
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-09-02
- Publication Date
- 2024-12-03
AI Technical Summary
Existing bone repair materials cannot effectively match bone regeneration rates, and cannot regulate mitochondrial sugar metabolism, affecting the bone healing process.
Using a staple fiber microsphere scaffold matching time sequence bone regeneration, triphenylphosphine-modified cerium and zinc-doped hydroxyapatite nanoparticles were synthesized by chemical precipitation and carbodiimide method and encapsulated in hydrocoagulation. In gel microspheres, a three-dimensional structure is formed by combining electrospinning technology to achieve controlled release of elements and mitochondrial varistor function.
The controlled release sequence and release rate of elements are achieved, matching the bone regeneration rate, and by restoring the mitochondrial function homeostasis of macrophages, inhibiting the inflammatory response and promoting bone repair.
Smart Images

Figure CN119055843A_ABST
Abstract
Description
Technical Field
[0001] The present invention belongs to the technical field of biomedical materials, and in particular relates to a short fiber microsphere scaffold capable of matching sequential bone regeneration, and a preparation method and application thereof. Background Art
[0002] In recent years, great progress has been made in the research of biomedical materials for repairing human tissue damage, among which bone damage repair materials have always been a hot topic in research. 10 (PO 4 ) 6 (OH) 2 ) is one of the most widely used calcium phosphate materials in clinical practice. HA has good biocompatibility and activity with living tissues and is an important material in artificial bones and tissue engineering. However, compared with the bones naturally formed in the human body, HA materials still have obvious defects, such as insufficient toughness and greater brittleness. Therefore, the mechanical properties of bone damage repair materials need to be able to provide sufficient support, and their degradation cycle needs to reasonably match the bone regeneration rate to facilitate bone ingrowth. However, since the repair of damaged bone tissue is a relatively complex and long process, the existing types of bone repair materials generally have the problem of not being able to match the bone regeneration rate well.
[0003] For example, although the various existing bone repair materials doped with metal ions can exert the role of metal ions in promoting osteogenesis and bone growth and better promote bone repair, most bone repair materials cannot control the release order and release rate of metal elements after being doped with metal ions to better match the bone regeneration rate.
[0004] For example, some researchers have developed various microsphere or fiber scaffold materials for bone repair. Although these materials can repair bones, due to the wide variety of materials and the fact that most of the raw materials used are degradable biomaterials, these bone repair materials have an uncontrollable overall degradation rate after implantation. When the degradation rate of the material is too fast, it cannot provide sufficient mechanical support for bone repair; when the degradation rate of the material is too slow, it is not conducive to the growth and formation of new bone. Therefore, these materials still cannot match the rate of bone regeneration well and cannot adapt to their performance requirements at different stages of bone regeneration.
[0005] Therefore, for bone repair materials, if the element release sequence and release rate of the scaffold material can be well controlled, and if it has good mechanical properties and degradation cycle, so that it can eventually match the rate of bone regeneration, it is the key factor for the success of bone repair. However, the existing bone repair materials cannot match the regeneration rate during bone repair, thus affecting the effect of bone repair.
[0006] On the other hand, in the process of developing bone repair materials, researchers also found that mitochondrial dysfunction and abnormal glucose metabolism are key issues in the destruction of bone immune homeostasis. As a key resistor regulating immune cell glucose metabolism, restoring mitochondrial homeostasis can effectively fight inflammation and initiate osteogenesis. It is divided into the following three stages:
[0007] Phase 1: Regulating macrophage glucose metabolism balance pro-inflammatory / anti-inflammatory phenotype is crucial
[0008] Glucose metabolism is an important event in controlling macrophage-mediated inflammatory responses. How to use glucose determines the fate of macrophages in immune regulation. As an important component of human immune cells, macrophages sense damage signals and are activated into a proinflammatory phenotype and secrete proinflammatory factors and chemokines to resist infection, amplify inflammatory responses, recruit immune cells, and regenerate related cells. However, the inflammatory storm caused by uncontrolled inflammatory macrophages under pathological conditions will destroy the body's immune balance, continue to expand the inflammatory response, and ultimately lead to tissue repair failure. Therefore, ensuring that macrophages transition from a proinflammatory phenotype to an anti-inflammatory phenotype at the right time is crucial to maintaining the immune microenvironment at the site of injury. Studies have shown that macrophages exert immunoregulatory functions through glucose metabolism mediated by glycolysis and oxidative phosphorylation, which is characterized by macrophages enhancing glucose uptake and glycolysis processes to transform into a proinflammatory phenotype (M1), and enhancing fatty acid oxidation and oxidative phosphorylation processes to transform into an anti-inflammatory phenotype (M2). Therefore, precise regulation of macrophage glucose metabolism balance pro-inflammatory / anti-inflammatory transition is crucial for tissue repair after injury.
[0009] Phase II: Maintaining mitochondrial homeostasis is an effective way to regulate macrophage metabolic reprogramming
[0010] Studies have shown that mitochondria are closely related to the glucose metabolism of macrophages. Mitochondrial homeostasis imbalance directly leads to the blockage of cellular oxidative phosphorylation, forcing cells to obtain energy through the glycolysis pathway. The effective activation of early wound macrophages depends on the joint regulation of glycolysis and mitochondrial metabolism. On the one hand, in the early stage of acute injury, macrophages tend to quickly supply energy and support anabolism through glycolysis rather than oxidative phosphorylation. The rate of energy production by glycolysis is 100 times that of oxidative phosphorylation. The biosynthetic intermediates (such as nucleotides) produced by the rapid start of glycolysis support inflammatory macrophages to secrete a variety of proinflammatory cytokines, including TNF-α, monocyte chemoattractant protein-1 (MCP-1), IL-6, and IL-4 / IL-13, which enhances the adaptability of macrophages to the injury microenvironment. Although the glycolysis process occurs in the cell matrix, it depends on mitochondrial function. The higher glycolysis rate and the continuous consumption of oxygen in the local environment lead to an imbalance in the ratio of NADH to NAD+ during cell proliferation, which further leads to redox imbalance and increases the production of reactive oxygen species (ROS). On the other hand, a large part of the glycolytic pyruvate is transported to the mitochondria for oxidation and ATP production, and by producing a large amount of ROS to stabilize the expression of HIF-1α, it promotes angiogenesis at the wound site and provides oxygen and nutrients for tissue healing. During the tissue remodeling stage, macrophages rely on oxidative phosphorylation and the toxic excitatory effects of mitochondria to increase macrophage adaptability, prolong their survival time in tissues, and thus exert long-term tissue remodeling functions. At the same time, M2 macrophages produce a large number of anti-inflammatory mediators that participate in tissue remodeling and repair, such as IL-10, TGF-β, and YM1. Therefore, it is crucial to precisely regulate mitochondrial homeostasis to ensure that macrophages in damaged tissues transition from glycolysis to oxidative phosphorylation in a timely manner.
[0011] Phase III: Mitochondria are key rheostats for innate immunity and bone homeostasis
[0012] As a key rheostat of innate immunity and bone homeostasis, mitochondria can affect immune responses by regulating the metabolic state of immune cells (represented by macrophages), and their functional state directly affects the normal progress of innate immunity and bone homeostasis. The transformation of a large number of inflammatory macrophages in damaged bone tissue into anti-inflammatory macrophages and the differentiation process of mesenchymal stem cells (MSCs) into osteoblasts are dependent on the metabolic shift of mitochondria from glycolysis to oxidative phosphorylation. In particular, mitochondrial ROS plays a crucial role in macrophage activation mediated by glucose metabolism, which activates inflammatory macrophages by activating nuclear factor κB (NF-κB) to enter the cell nucleus and induce its phosphorylation. Therefore, clearing macrophage mitochondrial ROS can effectively inhibit the activation of NF-κB, restore mitochondrial functional homeostasis and block glycolysis, thereby reprogramming macrophages to an anti-inflammatory phenotype. Currently, a variety of bioactive materials are used to remove ROS and regulate macrophage functional changes, including organic molecules (N-acetyl-L-cysteine, α-tocopherol and superoxide dismutase mimics, etc.) and inorganic nanomaterials (Ce-based nanomaterials, Mn-based nanomaterials and quantum dots, etc.). However, the above materials have poor degradation performance, low efficiency in targeting mitochondria, high toxicity, and cannot continuously regulate mitochondrial homeostasis, which limits their further application.
[0013] Therefore, if a bone repair material can be developed that matches the tissue immune gradient and continuously regulates mitochondrial functional homeostasis, accelerates the recovery of mitochondrial oxidative phosphorylation, and blocks the continuous glycolysis pathway of macrophages, it will provide greater applicability for the maintenance of innate immunity and bone homeostasis.
[0014] In summary, how to obtain a scaffold material that can well match the bone regeneration rate, and how to obtain a bone repair material that can match the tissue immune gradient and continuously regulate the homeostasis of mitochondrial function and block the continuous glycolysis pathway of macrophages to better promote bone repair has become a technical problem that needs to be solved urgently. Summary of the invention
[0015] The present invention is to solve the above technical problems, thereby providing a short fiber microsphere scaffold and preparation method and application that can match the time sequence of bone regeneration. The technical purpose of the present invention is to solve the problem that the element release sequence and release rate of the existing bone repair scaffold materials are uncontrollable, and the mechanical properties and degradation cycle are not suitable, and the bone regeneration rate cannot be well matched; on the other hand, it solves the problem that the existing bone repair materials cannot achieve the regulation of mitochondrial sugar metabolism, lack the ability to regulate macrophage sugar metabolism in the bone healing stage, and cannot achieve sugar metabolism-mediated macrophage function transformation to accelerate the bone regeneration process.
[0016] In order to achieve the above technical objectives, the technical solution adopted by the present invention is as follows:
[0017] The present invention first provides a method for preparing short fiber microspheres matching time-sequential bone regeneration, comprising the following steps:
[0018] (1) mixing zinc nitrate and calcium nitrate solution in proportion, and then co-precipitating with a phosphate solution to obtain zinc-doped hydroxyapatite nanoparticles; then using polyvinyl alcohol as a template and cyclohexamethylenetetramine as an alkaline solution to deposit cerium nitrate on the surface of the hydroxyapatite nanoparticles to obtain cerium- and zinc-doped hydroxyapatite nanoparticles;
[0019] (2) modifying the surface of cerium and zinc doped hydroxyapatite nanoparticles with 3-aminopropyltriethoxysilane to obtain nanoparticles with amino groups, and then grafting triphenylphosphine on the surface of the nanoparticles with amino groups by amide reaction to obtain triphenylphosphine grafted cerium and zinc doped hydroxyapatite nanoparticles;
[0020] (3) using methacrylated gelatin, polylactic acid and hexafluoroisopropanol to form a spinning solution, forming a uniform fiber membrane through an electrospinning device, and breaking the fiber membrane into electrospinning short fibers;
[0021] (4) preparing the triphenylphosphine-grafted cerium and zinc-doped hydroxyapatite nanoparticles obtained in step (2) and gelatin into microdroplets through a microfluidic device, and cross-linking them with 1-ethyl-(3-dimethylaminopropyl)carbodiimide and N-hydroxysulfosuccinimide reagents to form gelatin-based nanohydroxyapatite microspheres;
[0022] (5) The gelatin-based nano-hydroxyapatite microspheres obtained in step (2) are compounded with the electrospun short fiber suspension obtained in step (3), and after freeze-drying, a photoinitiator is used to generate carbon-carbon double bond crosslinking under ultraviolet light to obtain short fiber microspheres matching the timing of bone regeneration.
[0023] The preparation method provided by the present invention first synthesizes triphenylphosphine (TPP) and Ce / Zn ion-modified hydroxyapatite (CeZnHA) by chemical precipitation and carbodiimide method, and encapsulates it in hydrogel microspheres (PLA / GelMA), and then uses photocrosslinking to guide short fibers (FM) and CeZnHA to form a three-dimensional structure, and innovatively constructs an ion-activated mitochondrial rheostat fiber-microsphere polymerization system (FM@CeZnHA). Among them, CeZnHA with a fast degradation rate releases Ce / Zn ions to target and remove the oxidative stress environment of macrophage mitochondria and restore its metabolic function homeostasis. Through rapid redox reactions, it promotes the transition of macrophage sugar metabolism flux from glycolysis to oxidative phosphorylation, inhibits excessive early inflammatory response and quickly initiates osteogenesis. The FM network with a slow degradation rate provides a stable macrophage sugar metabolism conversion platform, continuously restores its mitochondrial homeostasis and accelerates its formation of ossification center through internal CeZnHA, and realizes efficient and continuous macrophage sugar metabolism-mediated bone immune cascade reaction. Therefore, the short fiber microspheres provided by the present invention can achieve a controllable release order and release rate of elements, thereby matching the bone regeneration rate; at the same time, the mitochondrial rheostat fiber microsphere system effectively restores the mitochondrial metabolic function of macrophages and the homeostasis of glucose metabolism flux in the early stage of bone injury, effectively combats the inflammatory storm and quickly initiates the osteogenesis process, thus opening up a new path for the treatment of bone defects.
[0024] In the above-mentioned synthesis method of the present invention, the doping method of Zn ions and Ce ions to obtain CeZnHA nanoparticles is extremely critical. As shown in the comparative example of the present invention, if Zn ions and Ce ions are lattice doped, the ratio of elements cannot be well controlled; and when Zn ions and Ce ions are surface coated, although the ratio of elements is easy to control, the order and rate of element release cannot be controlled; only when Zn ions are lattice doped and Ce ions are surface coated at the same time, the effect of easy control of element ratio and control of element release order and rate can be obtained, so that the short fiber microsphere scaffold can match the rate of bone regeneration.
[0025] At the same time, the synthesis method of the fiber scaffold and the microsphere in the present invention is also extremely critical. As shown in the comparative example of the present invention, when the microspheres and the fiber scaffold are cross-linked by EDC, the overall degradation rate of the scaffold material is too fast and cannot provide good mechanical support; and when the microspheres and the fiber scaffold are cross-linked by carbon-carbon double bonds, the overall degradation rate of the scaffold material is slow, which is not conducive to bone growth; only when EDC cross-linking is used when preparing microspheres and carbon-carbon double bonds are used when preparing fiber scaffolds, the overall degradation rate of the scaffold material can be adjusted, which can well match the rate of bone regeneration, and it is easy to deliver bioactive substances to achieve efficient bone repair effects.
[0026] Furthermore, in step (1), the molar ratio of zinc nitrate to calcium nitrate is 0.1-1:1, and the molar ratio of calcium nitrate to phosphate is 1.2-1.8:1.
[0027] It should be noted that the concentrations of polyvinyl alcohol and hexamethylenetetramine in step (1) are not strictly limited. It is recommended that the weight ratio of polyvinyl alcohol to nanoparticles is in the range of 1 to 10%, and the concentration of hexamethylenetetramine is in the range of 0.01 to 0.5 M.
[0028] Furthermore, in step (2), the weight ratio of 3-aminopropyltriethoxysilane to cerium and zinc doped nanoparticles is 0.1-0.8:1; the weight ratio of triphenylphosphine to nanoparticles with amino groups is 0.1-1:1.
[0029] Furthermore, the molecular weight of the polylactic acid in step (3) is 80,000 to 100,000 Da; and the weight ratio of the methacrylated gelatin to the polylactic acid is 4:1.
[0030] Furthermore, in step (3), the weight ratio of the polylactic acid to the methacrylated gelatin is 0.1 to 1:1, and the total weight of the polylactic acid and the methacrylated gelatin accounts for 1 to 30% of the weight of the hexafluoroisopropanol.
[0031] Furthermore, the cross-linking agent concentration of the EDC cross-linking in step (4) is 0.5M.
[0032] Furthermore, the photoinitiator in step (5) is LAP (phenyl (2,4,6-trimethylbenzoyl) lithium phosphate), and the time for carbon-carbon double bond crosslinking to occur is 5 minutes.
[0033] The second object of the present invention is to provide short fiber microspheres obtained by the preparation method as described above that can match the time sequence of bone regeneration.
[0034] The third object of the present invention is to provide the use of the short fiber microspheres as described above that can match the time sequence of bone regeneration as a bone repair material.
[0035] The beneficial effects of the present invention are as follows:
[0036] (1) The present invention provides a mitochondrial rheostat fiber microsphere scaffold that polymerizes short fibers with hydrogel microspheres and guides Ce and Zn-doped hydroxyapatite nanoparticles to composite, innovatively constructs a scaffold material that can control the order and rate of metal ion release, and whose degradation rate can match the bone regeneration rate, and can also restore macrophage mitochondrial function and glucose metabolism flux. The fiber microsphere scaffold can achieve better bone repair effect.
[0037] (2) The fiber microsphere scaffold provided by the present invention, wherein CeZnHA can dynamically remove ROS from macrophage mitochondria and restore their functional homeostasis, and the fiber network provides a stable macrophage glucose metabolism conversion platform, and the two are combined to efficiently and continuously accelerate the transformation of macrophages from glycolysis to oxidative phosphorylation, realizing the immune homeostasis of macrophages under oxidative stress and the immune-osteogenesis cascade process coordinated with glucose metabolism. The mitochondrial rheostat constructed by the short fiber-microsphere provides a new idea for the repair of various tissue injuries by restoring mitochondrial function and regulating macrophage glucose metabolism. BRIEF DESCRIPTION OF THE DRAWINGS
[0038] Figure 1 TEM images and element distribution, XPS and XRD patterns of CeZnHA nanoparticles; UV absorption spectra of CeZnHA, TPP and CeZnHA-TPP; HA, ZnHA, CeZnHA, CeZnHA-NH 3 and Zeta potential of CeZnHA-TPP; optical images and UV absorption spectra of Ce ions scavenging hydrogen peroxide; UV absorption spectra of different concentrations of CeZnHA-TPP scavenging ROS.
[0039] Figure 2 Optical photographs of PLA / GelMA electrospun membrane, homogenate suspension of PLA / GelMA electrospun membrane, freeze-dried scaffolds of homogenate suspension of PLA / GelMA electrospun membrane and cross-linked scaffolds; mechanical stability of cross-linked and uncross-linked PLA / GelMA scaffolds; optical photographs of gelatin microspheres and their particle size distribution; Fourier transform infrared spectra of scaffolds, scaffolds / HA, scaffolds / ZnHA, scaffolds / CeZnHA and scaffolds / CeZnHA-TPP; water absorption rate of PLA / GelMA scaffolds and PLA / GelMA / CeZnHA; degradation rate of PLA / GelMA; optical photographs of the degradation process of gelatin microspheres and their weight loss rate.
[0040] Figure 3 Schematic diagram of mitochondrial targeting of CeZnHA; CeZnHA targeting macrophage mitochondria; under LPS stimulation, the changes in mitochondrial membrane potential and ROS of macrophages after treatment with Control and FM\FM@HA and their statistical graphs (ns indicates no significant difference, * indicates p<0.05, *** indicates p<0.001, **** indicates p<0.0001).
[0041] Figure 4The mitochondrial metabolic state after co-culture of scaffolds and macrophages; a) SEM images of mitochondrial morphological changes in macrophages after treatment with different groups (LPS, Control and LPS+FM@CeZnHAP); b) statistical graphs of mitochondrial number and c) relative area in macrophages; heat maps of d) oxidative phosphorylation metabolites and e) glycolysis metabolites in macrophages after treatment with different groups; f) real-time OCR of macrophages after continuous injection of oligo, FCCP and rotenone (cell mitochondrial stress test); g) real-time OCR of macrophages after continuous injection of glucose, oligo and 2-DG (glycolysis stress test) (ns: no significant difference, **p<0.005, ****p<0.0001).
[0042] Figure 5 The expression levels of CD86 and CD206 after co-culture of scaffolds and macrophages; heat map of cytokine secretion levels (TNF-α and IL-10) after co-culture of scaffolds and macrophages; flow cytometry distribution diagram of M1 and M2 phenotypes after co-culture of scaffolds and macrophages; expression levels of related genes (IL-1β, INOS, Arg-1 and IL-10) after co-culture of scaffolds and macrophages; expression levels of glycolysis-related genes (HK2, GLUT and PKM2) after co-culture of scaffolds and macrophages; expression level of ATP after co-culture of scaffolds and macrophages (ns: no significant difference, *p<0.05, **p<0.005, ***p<0.001, ****p<0.0001).
[0043] Figure 6 Alkaline phosphatase and Alizarin red staining after co-culture of scaffold and macrophages; immunofluorescence staining of OCN and COL-Ⅰ after co-culture of scaffold and macrophages; expression levels of osteogenesis-related genes (ALP, COL-Ⅰ, RUNX2, OCN and OPN) after co-culture of scaffold and macrophages; quantitative analysis of OCN immunofluorescence staining (ns: no significant difference, *p<0.05, **p<0.005, ***p<0.001, ****p<0.0001).
[0044] Figure 7 Three-dimensional reconstruction of rat femoral condyle defects 2 and 4 weeks after scaffold implantation; bone regeneration evaluation (BV / TV, Tb.Th, Tb.Sp and BMD) at the femoral condyle defect site (ns: no significant difference, *p<0.05, **p<0.005, ***p<0.001, ****p<0.0001).
[0045] Figure 8HE and Masson staining of the femoral condyle defect after scaffold implantation at 2 and 4 weeks; the arrow in the figure indicates the ossification center formed by the hydrogel microspheres; quantitative analysis of the new bone area at the femoral condyle defect after scaffold implantation at 2 and 4 weeks (*p<0.05, ***p<0.001, **p<0.005, ****p<0.0001).
[0046] Fig. 9 The expression levels of CD206 and INOS at the femoral condyle defect site after scaffold implantation at 1 week, and the expression level of OPN at the femoral condyle defect site after scaffold implantation at 2 and 4 weeks; quantitative analysis of the expression levels of CD206 and INOS at the bone defect site at 1 week, and quantitative analysis of the expression level of OPN at the bone defect site at 2 and 4 weeks. Image J was used to complete the above statistical process; the circles and arrows in the figures represent the ossification centers formed by hydrogel microspheres (*p<0.05, **p<0.005, ***p<0.001, ****p<0.0001).
[0047] Fig.10 Release rates of Zn and Ce from CeZnHA nanoparticles obtained by different synthesis methods.
[0048] Fig.11 Degradation cycles of fiber microsphere scaffolds prepared by different cross-linking methods. DETAILED DESCRIPTION
[0049] In order to make the purpose, technical scheme and advantages of the present invention clearer, the present invention is described in detail below in conjunction with the embodiments. It is necessary to point out that the following embodiments are only used to explain and illustrate the present invention and are not used to limit the present invention. Some non-essential improvements and adjustments made by those skilled in the art based on the above invention content still belong to the protection scope of the present invention.
[0050] Example 1
[0051] 1. Experimental methods and characterization
[0052] 1. Experimental materials:
[0053] Polylactic acid (PLA, Mw = 80000 ~ 100000); 1,1,1,3,3,3-hexafluoro-2-propanol (HFIP); EDC (1-ethyl-(3-dimethylaminopropyl)carbodiimide); NHS (N-hydroxysulfosuccinimide); calcium nitrate; zinc nitrate; cerium nitrate; the above raw materials were purchased from Shanghai Aladdin Biochemical Technology Co., Ltd., and the remaining chemical reagents were purchased from Sigma-Aldrich.
[0054] 2. Preparation method of mitochondrial rheostat:
[0055] (1) First, hydroxyapatite (HA) nanoparticles were prepared by coprecipitation. Zinc nitrate and calcium nitrate solution were mixed in proportion, and then coprecipitated with phosphate solution to obtain zinc-doped hydroxyapatite nanoparticles (ZnHA); then, PVA (polyvinyl alcohol) was used as a template and hexamethylenetetramine was used as an alkaline solution to induce cerium nitrate to deposit on the HA surface to finally obtain Ce / Zn-doped HA (CeZnHA). Furthermore, APTES (3-aminopropyltriethoxysilane) was used to give amino groups to Ce / Zn-doped HA (CeZnHA-NH 3 ), and triphenylphosphine (TPP) with carboxyl groups was grafted onto the surface of the nanoparticles (CeZnHA-TPP) by amide reaction. The phase, morphology, element distribution and element valence of the nanoparticles were characterized by X-ray diffractometer, scanning electron microscope, transmission electron microscope and X-ray photoelectron spectroscopy. The surface charge of the nanoparticles and the absorption peak of the functional groups were characterized by Zeta potential analyzer and UV-visible absorption spectroscopy.
[0056] (2) Preparation of PLA / GelMA scaffolds: 0.8 g GelMA and 0.2 g PLA were dissolved in 10 mL hexafluoroisopropanol (HFIP) and formed into a uniform fiber membrane by an electrospinning machine. Further, the fiber membrane was broken by a high-speed homogenizer for later use. Gelatin / CeZnHA microdroplets were prepared by a microfluidic device and cross-linked by 0.5 M EDC to form gelatin / CeZnHA microspheres. Further, the gelatin / CeZnHA microspheres were composited with the PLA / GelMA spinning film suspension, freeze-dried, and cross-linked under ultraviolet light for 5 min using a pre-cooled LAP (phenyl (2,4,6-trimethylbenzoyl) lithium phosphate) solution to obtain a scaffold. The appearance and mechanical stability of the scaffold were recorded by a digital camera, and the morphology of the gelatin microspheres was recorded by an optical microscope and analyzed by image J for its particle size distribution. The structure of the composite scaffold and its single component were analyzed by Fourier transform infrared spectroscopy. The degradation rates of gelatin / CeZnHA microspheres and PLA / GelMA scaffolds were measured in PBS solution at 37 °C.
[0057] 3. Biocompatibility of mitochondrial rheostat:
[0058] BMSCs were extracted as follows: the femur and tibia of 80 g SD rats were surgically dissected and their medullary cavity was flushed to obtain bone marrow suspension. The bone marrow suspension was diluted with α-MEM (HyClone, America) medium supplemented with 10% FBS and 1% penicillin / streptomycin and cultured at 25 cm 2Cell culture flasks, the culture medium was changed every two days. The generations of BMSCs in the experiment were 3-6. DMEM (HyClone, America) and α-MEM extracts of the scaffolds were prepared and supplemented with 10% serum. DMEM and α-MEM extracts were co-cultured with Raw 264.7 and BMSCs in 96-well plates, respectively, and the culture medium was changed every two days. The cell viability was detected by CCK-8 kit (Beyotime, China) on days 1, 3 and 5, respectively. On the third day, skeleton staining was performed on Raw264.7 and BMSCs, respectively.
[0059] 4. Mitochondrial Targeting of Mitochondrial Rheostats:
[0060] To verify the mitochondrial targeting of CeZnHA, FITC was labeled on the surface of CeZnHA nanoparticles and incubated with Raw264.7 for 12 hours. CeZnHA nanoparticles labeled with FITC (Solarbio, China) and macrophage mitochondria labeled with mitochondrial probes were observed using laser confocal microscopy. Furthermore, the JC-1 kit (Beyotime, China) was used to detect the changes in the membrane potential of macrophage mitochondria after treatment with different materials. The ROS produced by macrophage mitochondria was detected using the DCFH-DA fluorescent probe (Beyotime, China). The red-green ratio of JC-1 and the fluorescence intensity of ROS were analyzed by image J.
[0061] 5. Immunofluorescence staining of macrophages after mitochondrial rheostat treatment:
[0062] Macrophage-specific markers (CD86 and CD206) were stained and recorded by confocal laser microscopy. Specifically, cells were fixed for 15 min by paraformaldehyde solution, then cells were permeabilized by 0.2% TritonX-100 for 10 min and blocked with the same host serum for 1 h. Then macrophages were treated for 12 h with CD86 antibody (Abcam, 1:1000) and CD206 antibody (Abcam, 1:1000). Actin-Tracker Red-555 (Beyotime, China) and DAPI (Beyotime, China) were used to stain the cytoskeleton and nucleus. The fluorescence intensity of CD86 and CD206 was detected by image J.
[0063] After the scaffolds were co-cultured with macrophages, the supernatant was collected to detect TNF-α and IL-10, and then the cells were collected and the ratio of inflammatory macrophages to anti-inflammatory macrophages was detected by flow cytometry. Real-time fluorescence quantitative PCR was used to detect the expression of macrophage-related genes (IL-1β, INOS, Arg-1, IL-10, HK2, GLUT and PKM2).
[0064] 6. In vivo immuno-osteogenic differentiation performance of mitochondrial rheostat:
[0065] To evaluate the osteogenic differentiation ability of the scaffolds, the conditioned medium (containing 100 nM dexamethasone (Solarbio, China), 50 μM ascorbic acid (Solarbio, China) and 10 mM sodium β-glycerophosphate (Solarbio, China)) after the scaffolds were co-incubated with macrophages was used to culture BMSCs, and alkaline phosphatase staining (Beyotime, China) and Alizarin red staining (Solarbio, China) were performed at 7 and 21 days, respectively. BMSCs osteogenic markers (OCN and COL-Ⅰ) were stained and recorded by laser confocal microscopy. Briefly, cells were fixed for 15 min by paraformaldehyde solution, followed by permeabilization with 0.2% Triton X-100 for 10 min and blocking with the same host serum for 1 h. Then BMSCs were treated for 12 h with OCN (Abcam, 1:1000) and COL-Ⅰ (Abcam, 1:1000) antibodies. Actin-Tracker Red-555 and DAPI were used to stain the cytoskeleton and nucleus. The fluorescence intensity of OCN and COL-Ⅰ was detected by image J. Real-time fluorescence quantitative PCR was used to detect the expression of macrophage-related genes (ALP, RUNX2, COL-Ⅰ, OPN and OCN).
[0066] 7. Animal experiments:
[0067] Femoral defect and scaffold implantation: All animal experiments were approved by the Animal Ethics Committee of Ruijin Hospital Affiliated to Shanghai Jiao Tong University (ethics number: 2023-03-SGKYJS-CWG-043). Forty male SD rats (280-320 g) were selected for this study and divided into five groups (n = 8): (1) control group; (2) FM group; (3) HA group; (4) ZnHA group; (5) CeZnHA group. The animals were anesthetized with isoflurane gas. A defect with a diameter of 3 mm and a depth of 4 mm was created in the femoral condyle using a medical Kirschner wire, and the scaffold was then filled into the defect site of the femoral condyle. Three days after surgery, antibiotics were injected daily and the survival status of the rats was observed. The rats were euthanized by overdose of anesthesia at 1, 2, and 4 weeks, respectively.
[0068] Micro-CT evaluation of bone regeneration: The bone quality of rats sampled at 2 and 4 weeks was evaluated by Micro-CT scanner (SkyScan 1276, Germany), and three-dimensional reconstruction images of bone tissue were obtained by mimics software. The trabecular volume fraction (BV / TV), bone mineral density (BMD), trabecular separation (Tb.SP) and trabecular thickness (Tb.Th) were analyzed to evaluate the bone regeneration status.
[0069] Histological evaluation: Femoral condyle samples were collected from rats at 1, 2, and 4 weeks, fixed with 4% paraformaldehyde for 48 h, and embedded in paraffin after decalcification for 4 weeks. The state of new bone in the defect was then evaluated by hematoxylin-eosin staining (HE) and Masson trichrome staining (Masson). In addition, the expression levels of CD206, INOS, and OPN in the tissue were analyzed by immunofluorescence staining and quantitatively analyzed by image J.
[0070] 2. Experimental Results and Discussion
[0071] 1. Design of mitochondrial rheostat
[0072] The mitochondrial rheostat includes mitochondrial targeting microspheres with a fast degradation rate and photo-crosslinked short fibers with a slow degradation rate. Its core preparation process is mitochondrial targeting Ce / Zn doped HA nanoparticles, fast degradation gelatin microspheres and photoresponsive PLA / GelMA short fiber scaffolds. Figure 1 As shown, first, Ce / Zn-doped HA nanoparticles were successfully prepared. In order to give Ce / Zn-doped HA nanoparticles mitochondrial targeting, triphenylphosphine was further grafted onto amino-modified CeZnHA through an amide reaction. The surface positive charge characteristics prompted it to bind to negatively charged mitochondria. Furthermore, gelatin microspheres loaded with CeZnHA were cross-linked by EDC, and finally gelatin microspheres with weak cross-linking strength were obtained, which could quickly and stably release mitochondrial-targeted CeZnHA. The weak cross-linking strength of gelatin microspheres made it impossible for them to maintain a fixed position for a certain period of time. Therefore, PLA / GelMA fiber membranes were further prepared by electrospinning technology and formed into short fiber solutions by a high-speed homogenizer. Then, they were uniformly mixed with gelatin microspheres loaded with CeZnHA and freeze-dried to form a stable fiber sponge structure. Finally, the fiber sponge scaffold was infiltrated with pre-cooled LAP solution and initiated by ultraviolet light to form a short fiber microsphere scaffold (called mitochondrial rheostat).
[0073] 2. Characterization of the physical and chemical properties of mitochondrial rheostat
[0074] HA nanoparticles were prepared by coprecipitation, and then PVA was used as a template and hexamethylenetetramine was used as an alkaline solution to induce the deposition of cerium nitrate on the HA surface to finally obtain Ce / Zn-doped HA. Furthermore, APTES was used to give amino groups to Ce / Zn-doped HA and triphenylphosphine with carboxyl groups was grafted on its surface by amide reaction (CeZnHA).
[0075] The morphology and element distribution of CeZnHA nanoparticles were characterized by scanning electron microscopy and transmission electron microscopy. Figure 1 , CeZnHA nanoparticles are composed of needle-like crystals with a length and width of 200nm and 20nm, respectively. The energy spectrum results show that Ce, Zn, Ca, P and O elements are evenly distributed on the surface of the nanoparticles, indicating the successful doping of Ce and Zn elements. XPS and XRD were used to further analyze the elemental valence and phase of CeZnHA nanoparticles. The results show that the XPS spectrum of CeZnHA nanoparticles contains characteristic peaks of Ce 3d, Zn2p, Ca 2p, P 2p and O1s, of which trivalent and tetravalent Ce elements are 94.71% and 5.29%, respectively. The XRD spectrum further confirms that CeZnHA belongs to hydroxyapatite, and its corresponding PDF card number is 09-0432.
[0076] The successful modification of triphenylphosphine was further confirmed by UV spectrophotometry. Two characteristic peaks of TPP (267 cm -1 and 274cm -1 ). Zeta potential results show that the surfaces of HA, ZnHA and CeZnHA are negatively charged, and the charge of CeZnHA after amino modification and TPP grafting is 8.36±0.21mV, which suggests that TPP-modified CeZnHAP nanoparticles can pass through the cell membrane and bind to mitochondria. It is worth noting that CeZnHA has the property of scavenging hydrogen peroxide, which is due to the redox ability of Ce ions. The catalytic ability of Ce element hydrogen peroxide was verified by o-phenylenediamine experiment. The results showed that cerium nitrate and CeZnHA can catalyze the decomposition of hydrogen peroxide and oxidize o-phenylenediamine, which is characterized by the gradual transformation of colorless solution into yellow solution. UV spectrophotometry experiments also further confirmed that CeZnHA catalyzes hydrogen peroxide to show corresponding characteristic peaks.
[0077] Next, the PLA / GelMA electrospinning membrane was successfully prepared and a uniform short fiber solution was formed by a high-speed homogenizer, and then freeze-dried and cross-linked by ultraviolet light to form a short fiber scaffold. Figure 2In terms of appearance, the short fiber scaffold after cross-linking showed less shrinkage as a whole, and the color changed from colorless to colored. In addition, the short fiber scaffold after cross-linking was more stable in structure, and the scaffold could stably maintain its shape under magnetic stirring without collapse.
[0078] Furthermore, uniform gelatin microspheres with controllable cross-linking strength were successfully prepared. The cross-linking strength depended on the EDC concentration and the particle size was about 100μm. Scanning electron microscopy recorded the morphology of gelatin microspheres loaded with CeZnHA, PLA / GelMA short fiber scaffolds and composite scaffolds. The surface of the gelatin microspheres loaded with CeZnHA has a porous structure, which is conducive to cell infiltration and the release of CeZnHA. The PLA / GelMA short fiber scaffold showed a loose porous structure with a fiber diameter of 500-1000nm. After the two were composited, the gelatin microspheres loaded with CeZnHA were evenly distributed in the PLA / GelMA short fiber scaffold without changing its inherent structural characteristics. The results of Fourier transform infrared spectroscopy showed that CeZnHA was successfully introduced into the gelatin microspheres and PO was present. 4 3- characteristic peaks.
[0079] The hydrophilicity of the scaffold determines the survival state of the cells. The loose and porous short fiber scaffold has good water absorption, which ensures that it can quickly absorb the biological fluid in the damaged tissue and accelerate the rapid hemostasis and cell infiltration of the wound. Figure 2 As shown in the figure, the maximum water absorption rate of the scaffold reached more than 960% within 5 minutes and remained stable under mechanical force. The appropriate degradation rate can ensure the orderly healing of tissues. The PLA / GelMA short fiber scaffold has a relatively slow degradation rate, which is only 58% degraded in 28 days; however, the gelatin microspheres loaded with CeZnHA are almost completely degraded in 28 days, which is attributed to the weak cross-linking degree of EDC cross-linked gelatin microspheres. This trend is confirmed by the optical images of the degradation experiment. In the first three days, the gelatin microspheres loaded with CeZnHA can maintain a stable morphology. On the seventh day, the microspheres began to degrade on a large scale, and on the 21st day, the microspheres degraded by more than 80%. This ensures that the system is conducive to maintaining the body's inherent inflammatory response in the first three days, and then begins to play an immunomodulatory role in inhibiting the body's inflammation.
[0080] The physicochemical properties of materials are highly correlated with the activity of immune cells, and considering the degradation rate of materials is an important means to guide immune regulation behavior. Studies have shown that designing polymer scaffolds with appropriate and adjustable degradation rates is conducive to the stable delivery of bioactive substances or cells to restore the tissue regeneration microenvironment, and polymer materials with slow degradation rates can effectively reduce inflammatory macrophage infiltration and promote immune cells to secrete anti-inflammatory factors, which leads to wound healing, inhibition of scar formation and vascular maturation, etc. Considering the optimal osteogenic window period of 4-8 weeks, stable double-bond modified gelatin and PLA were selected to form a short fiber scaffold. The corresponding degradation rate of 58% at 4 weeks not only ensures the release of active substances but also facilitates bone tissue ingrowth.
[0081] Precise control of the release of bioactive substances after 3 days is crucial to accelerate wound healing. As an excellent biocompatible material, gelatin has been designed to deliver a variety of bioactive substances. Glutaraldehyde is a classic chemical cross-linking agent to guide gelatin to form a stable three-dimensional network structure, but its biological toxicity causes thrombosis, calcification and poor endothelialization, which are not conducive to immune regulation. Therefore, the present invention selects EDC with good biocompatibility and adjustable cross-linking strength as a cross-linking agent and finally determines the concentration to be 0.5M. EDC cross-links the gelatin molecular chain to form an amide bond, and begins to stably release the encapsulated nanoparticles after 3 days, which ensures that the tissue will not be exposed to a large dose of nanoparticles, thereby ensuring its in vivo biocompatibility.
[0082] 3. Biocompatibility of mitochondrial rheostat
[0083] The biocompatibility of the scaffolds was evaluated by live-dead staining, cytoskeleton staining, and cell proliferation assays. Figure 2The cell experimental groups were Control, FM, FM@HA, FM@ZnHA and FM@CeZnHA groups. First, Calcein AM / PI staining was performed on the co-cultured macrophages and bone marrow mesenchymal stem cells on days 1 and 3, respectively. The results showed that macrophages and bone marrow mesenchymal stem cells maintained high cell viability, with almost no dead cells. Among them, the FM@ZnHA and FM@CeZnHA groups had a significant effect on promoting the proliferation of macrophages after 3 days of co-culture with macrophages, and the cell viability was significantly higher than that of the other groups. However, there was no significant difference in cell viability between the groups after co-culture with bone marrow mesenchymal stem cells. Then, on the third day, the cytoskeleton of co-cultured macrophages and bone marrow mesenchymal stem cells was stained, and the morphological changes of the scaffolds after co-culture with cells were detected using phalloidin. The macrophages in the Control and FM groups became larger in morphology and extended irregular tentacles, which were consistent with the phenotype of inflammatory macrophages, while the macrophages in the FM@HA, FM@ZnHA and FM@CeZnHA groups began to have slender pseudopodia and were spindle-shaped as a whole, which were consistent with anti-inflammatory macrophages. In addition, there was no significant difference in the morphology of bone marrow mesenchymal stem cells after treatment in the Control, FM, FM@HA, FM@ZnHA and FM@CeZnHA groups, and they were spindle-shaped as a whole.
[0084] In summary, the scaffold designed in the present invention has normal cell viability after co-culture with macrophages and bone marrow mesenchymal stem cells, meeting the subsequent experimental requirements and normal bone implantation requirements.
[0085] 4. Mitochondrial rheostat targets macrophage mitochondria and regulates their metabolites
[0086] Studies have shown that ROS has the ability to reprogram macrophages from a pro-inflammatory phenotype (M2) to a pro-inflammatory phenotype (M1), and targeted regulation of mitochondrial ROS levels is essential for coordinating the functional transformation of macrophages. In order to verify the mitochondrial targeting of CeZnHA, the present invention modifies FITC on the surface of CeZnHA particles and co-cultures them with macrophages for 12 hours. The co-localization results of mitochondrial staining and FITC-labeled CeZnHA show that the green fluorescence and red fluorescence of CeZnHA nanoparticles overlap as yellow signals and are widely distributed inside the cells, indicating that CeZnHA nanoparticles can be effectively internalized by macrophages and accumulated around mitochondria. Stereoscopic scanning of macrophages by laser confocal microscopy and 3D reconstruction of images further confirm that CeZnHA nanoparticles have mitochondrial targeting function.
[0087] JC-1 is a visualized fluorescent probe of mitochondrial membrane potential. When the mitochondrial membrane potential is high, JC-1 aggregates in the mitochondrial matrix to form polymers and produce the first fluorescence. When the mitochondrial membrane potential is low, JC-1 cannot aggregate in the mitochondrial matrix but becomes a JC-1 monomer and produces the second fluorescence. The relative ratio of the two fluorescences is an important indicator for measuring mitochondrial depolarization. Figure 3 The results of JC-1 staining of macrophages after co-culture with the scaffold showed that in the presence of LPS, a large number of second-fluorescence JC-1 monomers appeared in the mitochondria of macrophages in the Control and FM groups, while more first-fluorescence JC-1 aggregates were detected in the mitochondria of macrophages in the FM@HA, FM@ZnHA and FM@CeZnHA groups, and the trend was increasing. Quantitative analysis of JC-1 fluorescence showed that the ratio of the first and second fluorescence intensities of macrophage mitochondria in the FM@ZnHA and FM@CeZnHA groups was significantly higher than that in the other groups, especially in the FM@CeZnHA group.
[0088] Studies have shown that under the stimulation of lipopolysaccharide (LPS), the metabolic mode of macrophages changes from producing ATP through oxidative phosphorylation to glycolysis, while increasing the level of succinate. The increased mitochondrial oxidation of succinate and the increase in mitochondrial membrane potential jointly drive the production of mitochondrial reactive oxygen species (ROS). Therefore, clearing mitochondrial ROS is an effective means to reprogram the metabolic mode of macrophages. In order to evaluate the ability of the scaffold to clear LPS-induced macrophage ROS, the expression level of ROS in macrophages was detected by fluorescent probe. The Control and FM groups produced a large amount of ROS under LPS stimulation and the fluorescence intensity was strong. The ROS level of macrophages in the FM@HA and FM@ZnHA groups showed a significant downward trend, indicating that HA and ZnHA have a positive effect on resisting macrophage oxidative stress. It is worth noting that the expression of ROS in macrophages in the FM@CeZnHA group was low, and the cell oxidative stress caused by LPS returned to normal levels. Studies have shown that the Zn element improves the oxidative phosphorylation of STAT3, weakens the production of mitochondrial ROS and the dissipation of mitochondrial membrane potential. In addition, Zn has also been shown to be beneficial in restoring damaged mitochondrial networks and morphology, which helps to combat abnormal mitochondrial morphology caused by elevated ROS. Ce has been shown to be highly efficient in removing intracellular ROS, thanks to its Ce 3+ and Ce 4+ The rapid transformation of Ce 3+ Eliminate O associated with inflammatory response and cell death by mimicking superoxide dismutase 2 - and OH, Ce 4+ Eliminate H by mimicking catalase 2 O 2 .
[0089] Inorganic nanoparticles can be internalized and reprocessed by immune cells, thereby regulating the fate and function of immune cells. On the one hand, the metabolic activity of immune cells is affected by the dose of nanoparticles. Excessive nanoparticles will induce immune cells to secrete a large number of inflammatory factors, thereby causing irreversible inflammatory reactions and aggravating tissue damage. On the other hand, the inherent physicochemical properties of nanoparticles can regulate the metabolic process of immune cells. During the internalization process, nanoparticles can simulate the apoptosis function to activate immune cells to perform the clearance function.
[0090] Considering that macrophage phenotype is mainly regulated by mitochondrial function and related metabolism, we studied the changes in mitochondrial morphology and metabolites after CeZnHA entered macrophages. Figure 4 As shown in the figure, under LPS stimulation, the electron density of macrophage mitochondria increased, shrank, and the cristae disappeared. Under the protection of CeZnHA, macrophage mitochondria were able to resist LPS stimulation and return to normal cell mitochondrial morphology. Cell metabolites are important indicators for judging cell phenotype and function. Therefore, in order to further explore the effect of scaffolds on macrophage mitochondrial metabolites, after co-incubation of macrophages with DMEM medium, DMEM medium containing LPS, and DMEM medium extracted from scaffolds, liquid chromatography-tandem mass spectrometry (LC-MS / MS) was used to analyze that enhanced glycolysis and interruption of the TCA cycle were associated with pro-inflammatory M1-like macrophage polarization, while anti-inflammatory M2-like macrophages were characterized by mitochondrial respiration fueled by glutamine and fatty acids. The results showed that there were 20 differentially expressed metabolites between the LPS group and the Control group, of which 14 differentially expressed metabolites were related to the TCA cycle and 6 were related to glycolysis. Heatmap and quantitative analysis showed that after co-incubation of FM@CeZnHA scaffolds with macrophages, several key metabolites of glycolysis, such as D-Fructose 1,6-bisphosphate, BD-Fructose 6-phosphate, D-Glucose 6-phosphate, Lactic acid, 3-Phospho-D-glycerate, and Phosphoenolpyruvic acid, were lower than those in the LPS group and had significant differences, but no significant difference was found in the Control group. For the TCA cycle, heatmap and quantitative analysis showed that after co-incubation of FM@CeZnHA scaffolds with macrophages, Acetyl coenzyme A, Adenosine 5'-diphosphate, Adenosine 5'-triphosphate, and Citric acid were significantly higher than those in the LPS group, but no statistical difference was found in the Control group. These data suggest that co-incubation of FM@CeZnHA scaffolds with macrophages may reduce cellular glycolysis and increase the levels of mitochondrial TCA cycle metabolites associated with M2 polarization.
[0091] Extracellular flux analysis was used to further verify the effect of FM@CeZnHA scaffold on the metabolic state of macrophages. The control group contained normal macrophages without any treatment. The oxidative phosphorylation level of macrophages was evaluated by detecting the real-time oxygen consumption rate (OCR) of macrophages by injecting oligomycin (Oligo), carbonyl cyanide trifluoromethoxyphenylhydrazone (FCCP) and rotenone. The basal respiration, maximum respiration and ATP production of cells in the FM@CeZnHA scaffold group were significantly higher than those in the LPS group, and there was no significant difference with the control group. At the same time, the real-time extracellular acidification rate (ECARs) of macrophages was detected by injecting glucose, oligomycin (Oligo) and 2-deoxy-d-glucose (2-DG) to detect the glycolytic metabolic capacity. Among them, the macrophages treated with FM@CeZnHA scaffold significantly reduced the extracellular acidification rate, and the large amount of lactic acid secreted by the LPS group aggravated the extracellular acidification rate.
[0092] 5. In vitro immunomodulatory effects of mitochondrial rheostat
[0093] To further verify the immunomodulatory function of the scaffold on macrophages, immunofluorescence staining, flow cytometry, enzyme-linked immunosorbent assay, and real-time fluorescence quantitative PCR were used to evaluate the phenotypic transformation of macrophages, the expression of inflammatory / anti-inflammatory factors, and the metabolic state. Immunofluorescence analysis was used to analyze the expression of markers of the pro-inflammatory phenotype (CD86) and anti-inflammatory phenotype (CD206) of macrophages, such as Figure 5 Compared with the Control and FM groups, the co-cultured macrophages in the FM@HA, FM@ZnHA and FM@CeZnHA groups expressed less CD86 and more CD206. Flow cytometry results showed that the percentage of anti-inflammatory macrophages in the FM@HA, FM@ZnHA and FM@CeZnHA groups was significantly higher than that in the other groups. Furthermore, the mRNA expression of anti-inflammatory macrophages and pro-inflammatory macrophage-related genes was detected at the molecular level by PCR experiments. The results showed that the macrophages in the FM@HA, FM@ZnHA and FM@CeZnHA groups significantly increased the genes related to the anti-inflammatory phenotype of macrophages (Arg-1 and IL-10) and down-regulated the genes related to the pro-inflammatory phenotype (IL-1β and INOS), and there were significant differences with the other groups. Among them, the FM@CeZnHA group had the strongest effect in promoting the polarization of macrophages to the anti-inflammatory phenotype.
[0094] Analysis of inflammatory and anti-inflammatory factors secreted by macrophages is an effective means to evaluate the metabolic state of macrophages. After 24 h of co-culture of scaffolds and macrophages, the supernatant was collected and analyzed by enzyme-linked immunosorbent assay for the concentrations of TNF-α and IL-10. Figure 5The results showed that the FM@HA, FM@ZnHA and FM@CeZnHA groups significantly promoted the secretion of anti-inflammatory factors by macrophages, while reducing the secretion of pro-inflammatory factors, which helped the macrophages polarize to an anti-inflammatory phenotype rather than a pro-inflammatory phenotype. The metabolic state of macrophages after scaffold culture was further analyzed by PCR and the expression of macrophage glycolysis and oxidative phosphorylation-related genes was detected. These data indicate that the FM@HA, FM@ZnHA and FM@CeZnHA groups inhibited the glycolysis process of macrophages and promoted the oxidative phosphorylation process of mitochondria.
[0095] 6. Mitochondrial rheostat’s immuno-bone differentiation regulation performance
[0096] To evaluate osteogenic differentiation mediated by macrophage immunomodulation, we stimulated BMSCs by co-culturing the scaffolds with the conditioned medium of macrophages and performed ALP staining and Alizarin red staining at 7 and 14 days, respectively. Figure 6 ALP staining results showed that compared with the Control and FM groups, the staining depth of FM@HA, FM@ZnHA and FM@CeZnHA groups was deeper, and the expression of alkaline phosphatase in the FM@CeZnHA group was 5.33, 6.66, 1.80 and 1.36 times that of the Control, FM, FM@HA and FM@ZnHA. Alizarin red staining showed that the number of calcium nodules in the FM@CeZnHA group was more and the color was darker. Quantitative data showed that the mineralization degree of the FM@CeZnHA group was 2.3, 2.03, 1.47 and 1.18 times that of the Control, FM, FM@HA and FM@ZnHA, respectively. Further, we used immunofluorescence staining and quantitative real-time fluorescence PCR to evaluate the relative expression levels of osteogenic-related proteins and genes in BMSCs co-cultured with scaffolds on day 7. The immunofluorescence images of OCN and COL-Ⅰ on the 7th day showed that the FM@CeZnHA group had stronger osteogenic differentiation ability than the Control, FM, FM@HA and FM@ZnHA groups, and the quantitative data were consistent with the staining results. In addition, we detected the relative expression of osteogenic-related genes at the molecular level, and the PCR results confirmed that BMSCs in the FM@CeZnHA group significantly upregulated the expression levels of osteogenic-related genes (ALP, RUNX2, COL-Ⅰ, OCN and OPN), and the trend was consistent with the immunofluorescence staining results of OCN and COL-Ⅰ. In summary, the osteogenic differentiation experiment showed that the FM@CeZnHA scaffold precisely regulated the polarization of macrophages and their metabolites, and realized the osteogenic differentiation process mediated by the immune microenvironment.
[0097] 7. Mitochondrial rheostat in vivo immune-bone regeneration performance
[0098] Based on the above results, the mitochondrial rheostat targeted mitochondria, precisely regulated macrophage glucose metabolism, and then transformed macrophages into an anti-inflammatory phenotype, promoting the osteogenic differentiation of BMSCs in vitro. A rat femoral condyle defect model was established to evaluate the effects of the scaffold on the early immune microenvironment and later osteogenesis. All animal experiments were approved by the Animal Ethics Committee of Ruijin Hospital Affiliated to Shanghai Jiao Tong University (Ethics Permit No.: 2023-03-SGKYJS-CWG-043). The experimental animals were SD male rats weighing 280-320g, and the experimental groups were Control, FM, FM@HA, FM@ZnHA, and FM@CeZnHA.
[0099] In vivo evaluation included imaging and histological evaluation, quantitative and qualitative comparison of bone regeneration indicators after scaffold implantation. In order to more intuitively evaluate the bone ingrowth, Micro-CT scanning and three-dimensional reconstruction were performed on the femoral condyle defect site of rats at 2 and 4 weeks after surgery. Figure 7 At 2 weeks, there was less new bone tissue in the Control and FM groups, and new bone tissue gradually grew in the FM@HA, FM@ZnHA, and FM@CeZnHA groups, which was due to the excellent osteoconductivity and osteoinductivity of HA, but the overall density of the defect was low. At 4 weeks, there was still less new bone in the defect of the Control and FM groups, and the defects of the FM@HA, FM@ZnHA, and FM@CeZnHA groups were completely closed and new bone tissue began to grow in large quantities, and the overall bone density of the defect increased compared with 2 weeks. Quantitative data analyzed the bone density, trabecular thickness, trabecular separation, and new bone volume of each group. The results showed that the FM@CeZnHA group had a faster osteogenesis rate and better bone quality. Based on the imaging analysis data, we speculate that in addition to filling the defect in the early stage of injury, the scaffold can also promote cell migration to the scaffold and osteogenic differentiation by virtue of the osteoconductivity and osteoinduction of HA. It is worth noting that the immunomodulatory effect of Zn and Ce ions on macrophages plays a vital role in maintaining the early immune microenvironment, which further promotes the later bone regeneration process.
[0100] The early and late osteogenic capacity of the scaffolds was further evaluated by histological evaluation of the defect sites using Masson's trichrome and hematoxylin and eosin staining. Figure 8, 2 weeks after surgery, all groups showed different degrees of unhealed defects, among which the Control and FM groups had less new bone growth due to the lack of osteoconduction and osteoinduction properties. FM@HA, FM@ZnHA and FM@CeZnHA groups were able to significantly promote cell migration to the defect area and promote osteogenic differentiation. Among them, the collagen fibers in the FM@ZnHA and FM@CeZnHA groups were orderly arranged, the bone maturity was high, and the osteogenic capacity was significantly higher than that of the other groups. At 4 weeks after surgery, the defect areas in the Control and FM groups were still not completely healed, which may be related to the poor early immune microenvironment and osteoconduction. The new bone tissue in the FM@HA, FM@ZnHA and FM@CeZnHA groups had completely filled the defect area, and their trabecular thickness, bone separation and bone maturity were significantly higher than those of the other groups. Although the bone defect in the FM@HA group was completely closed, the bone density was lower than that in the FM@ZnHA and FM@CeZnHA groups. In the early stage of macrophage infiltration in the scaffold, HA could not accurately target the macrophage mitochondria to regulate the macrophage metabolic process, resulting in its inability to achieve accurate early immune microenvironment regulation in the defect. The weak immune regulation ability could not promptly promote the transformation of macrophages to an anti-inflammatory phenotype, which further led to the weaker osteogenesis ability of the FM@HA group.
[0101] In the early injury microenvironment, the temporal transition of inflammatory macrophage and anti-inflammatory macrophage phenotypes is a key factor in achieving efficient bone healing and bone quality. We regulated the functional transition of macrophages in the early bone injury microenvironment by releasing CeZnHAP nanoparticles from the scaffold. Fig. 9 , immunofluorescence staining was used to detect surface markers of macrophages around the scaffold 1 week after surgery. The results showed that the anti-inflammatory macrophages in the bone defect of FM@HA, FM@ZnHA and FM@CeZnHA groups increased significantly, and the expression of their specific marker CD206 was upregulated and the expression of INOS was downregulated. Quantitative data showed that the proportion of anti-inflammatory macrophages in FM@HA, FM@ZnHA and FM@CeZnHA groups was 1.31, 1.61 and 1.63 times that of control, respectively. In addition, the number of inflammatory macrophages in the Control and FM groups was much higher than that in the other groups, among which the FM@CeZnHA group had the least inflammatory macrophage infiltration, which may be due to the fact that CeZnHA targeted macrophage mitochondria to clear ROS, thereby prompting macrophages to tend to transform into anti-inflammatory macrophages rather than inflammatory macrophages. To further determine the immunomodulatory effect of macrophage functional transformation on bone regeneration, the expression of osteoblast-related protein (OPN, an important bone matrix protein closely related to bone formation and development) was evaluated by immunofluorescence at 2 and 4 weeks after scaffold transplantation. The results showed that compared with the Control and FM groups, the expression of OPN in the FM@HA, FM@ZnHA and FM@CeZnHA groups was significantly increased.
[0102] Conclusion
[0103] In summary, the above embodiments demonstrate that the mitochondrial rheostat of the present invention affects the functional transformation of macrophages by regulating glucose metabolism. The dual-degradation-rate mitochondrial rheostat rapidly releases CeZnHA in the early stage and accurately targets macrophage mitochondria and removes ROS, inhibiting macrophage glycolysis and enhancing its oxidative phosphorylation process, prompting macrophages to be reprogrammed to an anti-inflammatory phenotype. In addition, the short fiber scaffold provides a stable ossification platform in the later stage, accelerates the formation of ossification centers by hydrogel microspheres that respond to immune responses, and ultimately achieves efficient bone regeneration. Therefore, the macrophage glucose metabolism transformation guided by the mitochondrial rheostat is an efficient immune response behavior, which provides a new perspective for the development of immune strategies to treat bone regeneration.
[0104] Comparative Example 1
[0105] Different synthesis processes of CeZnHA nanoparticles of Example 1 of the present invention were explored. The specific synthesis method is shown in Table 1:
[0106] Table 1
[0107]
[0108] The ion release rates of CeZnHA nanoparticles obtained by different synthesis methods are shown in Fig.10 shown.
[0109] From Table 1 and Fig.10 It can be seen that when Zn and Ce ions are lattice doped, the ratio of elements cannot be well controlled; and when Zn and Ce ions are surface coated, although the ratio of elements is easy to control, the order and rate of element release cannot be controlled. Only when Zn ions are lattice doped and Ce ions are surface coated at the same time, can the effect of easy control of element ratio, control of element release order and rate be obtained, so that the short fiber microsphere scaffold can match the rate of bone regeneration.
[0110] Comparative Example 2
[0111] The cross-linking method of the composite material of Example 1 of the present invention was explored, and the specific method is shown in Table 2:
[0112] Table 2
[0113]
[0114] Degradation time of scaffold materials prepared by different cross-linking methods Fig.11 shown.
[0115] From Table 2 and Fig.11It can be seen that when the microspheres and the fiber scaffolds are cross-linked by EDC, the overall degradation rate of the scaffold material is too fast and cannot provide good mechanical support; when the microspheres and the fiber scaffolds are cross-linked by carbon-carbon double bonds, the overall degradation rate of the scaffold material is slow, which is not conducive to bone ingrowth. Only when EDC cross-linking is used when preparing microspheres and carbon-carbon double bonds are used when preparing fiber scaffolds, can the overall degradation rate of the scaffold material be adjustable, which can well match the rate of bone regeneration, and it is easy to deliver bioactive substances to achieve efficient bone repair effects.
Claims
1. A method for preparing short fiber microspheres for matching time-sequential bone regeneration, characterized in that: The following steps are involved: (1) mixing zinc nitrate and calcium nitrate solution in proportion, and then co-precipitating with a phosphate solution to obtain zinc-doped hydroxyapatite nanoparticles; then using polyvinyl alcohol as a template and cyclohexamethylenetetramine as an alkaline solution to deposit cerium nitrate on the surface of the hydroxyapatite nanoparticles to obtain cerium- and zinc-doped hydroxyapatite nanoparticles; (2) modifying the surface of cerium and zinc doped hydroxyapatite nanoparticles with 3-aminopropyltriethoxysilane to obtain nanoparticles with amino groups, and then grafting triphenylphosphine on the surface of the nanoparticles with amino groups by amide reaction to obtain triphenylphosphine grafted cerium and zinc doped hydroxyapatite nanoparticles; (3) using methacrylated gelatin, polylactic acid and hexafluoroisopropanol to form a spinning solution, forming a uniform fiber membrane through an electrospinning device, and breaking the fiber membrane into electrospinning short fibers; (4) preparing the triphenylphosphine-grafted cerium and zinc-doped hydroxyapatite nanoparticles obtained in step (2) and gelatin into microdroplets through a microfluidic device, and cross-linking them with 1-ethyl-(3-dimethylaminopropyl)carbodiimide and N-hydroxysulfosuccinimide reagents to form gelatin-based nanohydroxyapatite microspheres; (5) The gelatin-based nano-hydroxyapatite microspheres obtained in step (2) are compounded with the electrospun short fiber suspension obtained in step (3), and after freeze-drying, a photoinitiator is used to generate carbon-carbon double bond crosslinking under ultraviolet light to obtain short fiber microspheres matching the timing of bone regeneration.
2. The preparation method according to claim 1, characterized in that: In step (1), the molar ratio of zinc nitrate to calcium nitrate is 0.1-1:1, and the molar ratio of calcium nitrate to phosphate is 1.2-1.8:
1.
3. The preparation method according to claim 1 or 2, characterized in that: The weight ratio of 3-aminopropyltriethoxysilane to the cerium and zinc doped nanoparticles in step (2) is 0.1-0.8:
1.
4. The preparation method according to claim 1 or 2, characterized in that: The weight ratio of triphenylphosphine to the nanoparticles with amino groups in step (2) is 0.1 to 1:
1.
5. The preparation method according to claim 1 or 2, characterized in that: The molecular weight of the polylactic acid in step (3) is 80,000 to 100,000 Da; the weight ratio of the methacrylated gelatin to the polylactic acid is 4:
1.
6. The preparation method according to claim 1 or 2, characterized in that: The weight ratio of the polylactic acid to the methacrylated gelatin in step (3) is 0.1 to 1:1, and the total weight of the polylactic acid and the methacrylated gelatin accounts for 1 to 30% of the weight of the hexafluoroisopropanol.
7. The preparation method according to claim 1 or 2, characterized in that: The cross-linking agent concentration of EDC cross-linking in step (4) is 0.5M.
8. The preparation method according to claim 1 or 2, characterized in that: The photoinitiator in step (5) is LAP, and the time for carbon-carbon double bond crosslinking to occur is 5 minutes.
9. Short fiber microspheres capable of matching time-sequential bone regeneration obtained by the preparation method according to any one of claims 1 to 8.
10. Use of the short fiber microspheres capable of matching time-sequential bone regeneration as claimed in claim 9 as bone repair materials.
